Galectin Therapeutics - 53 Year Dividend History | GALT
Historical dividend payout and yield for Galectin Therapeutics (GALT) since 1971. The current TTM dividend payout for Galectin Therapeutics (GALT) as of November 20, 2024 is $0.00. The current dividend yield for Galectin Therapeutics as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.171B |
$0.000B |
|
Galectin Therapeutics Inc. is a drug development company engaged in the development new therapies for fibrotic disease and cancer. The Company uses its carbohydrate technology that targets galectin proteins, the key mediators of biologic and pathologic function. Galectin Therapeutics uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates with specific molecular weights. Galectin Therapeutics, formerly known as Pro-Pharmaceuticals, Inc. is headquartered in Newton, Massachusetts.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
